PHP
SILK

Parkman Healthcare Partners’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Parkman Healthcare Partners’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-848,897
Closed -$15.6M – 110
2024
Q1 		$15.6M Buy
848,897
+303,662
+56% +$4.82M 1.91% 15
2023
Q4 		$6.69M Buy
545,235
+295,894
+119% +$2.78M 0.94% 35
2023
Q3 		$3.74M Sell
249,341
-58,184
-19% -$1.21M 0.68% 42
2023
Q2 		$9.99M Buy
307,525
+67,661
+28% +$2.47M 1.73% 19
2023
Q1 		$9.39M Buy
239,864
+146,559
+157% +$7.17M 2.04% 16
2022
Q4 		$4.93M Buy
+93,305
New +$4.54M 1.31% 27
2021
Q2 		– Sell
-20,000
Closed -$1.01M – 96
2021
Q1 		$1.01M Sell
20,000
-47,854
-71% -$2.66M 0.24% 75
2020
Q4 		$4.27M Sell
67,854
-52,161
-43% -$3.24M 1.09% 35
2020
Q3 		$8.07M Buy
120,015
+15
+0% +$819 2.14% 15
2020
Q2 		$5.03M Sell
120,000
-15,000
-11% -$576K 1.42% 31
2020
Q1 		$4.25M Sell
135,000
-60,000
-31% -$2.4M 1.97% 17
2019
Q4 		$7.87M Buy
+195,000
New +$6.83M 2.27% 15

Other funds holding SILK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Parkman Healthcare Partners's SILK Position: Q2 2024 in Review

Parkman Healthcare Partners sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2024, closing a stake of 848,897 shares — an estimated $15.6M sold.

Parkman Healthcare Partners first reported a position in SILK in Q4 2019 and held it in 12 quarters. The position peaked at $15.6M in Q1 2024. 172 funds tracked by Wall St. Rank hold SILK as of Q2 2024.

  • Parkman Healthcare Partners reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Parkman Healthcare Partners sold 848,897 Silk Road Medical, Inc. Common Stock shares in Q2 2024, an estimated $15.6M.
  • Parkman Healthcare Partners first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • Parkman Healthcare Partners's Silk Road Medical, Inc. Common Stock position peaked at $15.6M in Q1 2024.
  • 172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2024.

Based on Parkman Healthcare Partners's 13F filing for Q2 2024, filed 14 Aug 2024.